Microbiome Modulation in Parkinson's Disease

The gut microbiota shares a symbiotic relationship with the human host. Dysbiosis is linked with several neurological pathologies including Parkinson’s disease (PD). Here is the latest research on the modulation of PD by the gut microbiota.

March 4, 2020

Alzheimer's disease and gastrointestinal microbiota; impact of Helicobacter pylori infection involvement

The International Journal of Neuroscience
Michael DoulberisJannis Kountouras
May 23, 2020

Gut Microbiota and Disorders of the Central Nervous System

The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
Claudia VuottoGiovanna Borsellino
April 6, 2020

The gut microbiome in Parkinson's disease: A culprit or a bystander?

Progress in Brain Research
Ali KeshavarzianRoberto Cilia
March 6, 2020
Review
Open Access

Engineering probiotics as living diagnostics and therapeutics for improving human health

Microbial Cell Factories
Zhao ZhouQipeng Yuan
April 10, 2020
Review
Open Access

Volatilomes of Bacterial Infections in Humans

Frontiers in Neuroscience
Moamen M Elmassry, Birgit Piechulla
February 29, 2020

Impact of gastrointestinal physiology on drug absorption in special populations--An UNGAP review

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Cordula StillhartAnette Müllertz
April 9, 2020
Review
Open Access

Fecal Microbiota Transplantation in Neurological Disorders

Frontiers in Cellular and Infection Microbiology
Karuna E W VendrikMaria Fiorella Contarino
March 27, 2020
Review
Open Access

Leucine Rich Repeat Kinase 2 and Innate Immunity

Frontiers in Neuroscience
Diba Ahmadi Rastegar, Nicolas Dzamko
April 13, 2020
Review

Perinatal Inflammation Reprograms Neuroendocrine, Immune, and Reproductive Functions: Profile of Cytokine Biomarkers

Inflammation
Marina IzvolskaiaLiudmila Zakharova
March 27, 2020

Sphingolipids in food and their critical roles in human health

Critical Reviews in Food Science and Nutrition
Xiaoxu WangChanghu Xue
April 21, 2020

Investigation of Potential Brain Microbiome in Alzheimer's Disease: Implications of Study Bias

Journal of Alzheimer's Disease : JAD
Susan WestfallGiulio M Pasinetti
May 29, 2020
Review

Clinical implications of gastric complications on levodopa treatment in Parkinson's disease

Parkinsonism & Related Disorders
Ronald F PfeifferRajesh Pahwa
July 1, 2020
Open Access

Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report

The Journal of International Medical Research
Sabine Hazan
May 2, 2020

Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Mihai S CirsteaSilke Appel-Cresswell
May 19, 2020

Resistome and virulome study on pathogenic Streptococcus agalactiae Guangzhou-SAG036

Microbial Pathogenesis
Zhenbo XuBirthe V Kjellerup
July 7, 2020
Review
Open Access

Parkinson's Disease and the Gut: Future Perspectives for Early Diagnosis

Frontiers in Neuroscience
Jana HarsanyiovaAlzbeta Kralova Trancikova
April 14, 2020

Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders

Current Topics in Medicinal Chemistry
Sreyashi ChandraPrem Prakash Tripathi

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/microbiome-modulation-in-parkinsons/f4f785f1-a735-4989-af87-13dc7e25ad75